Phase II Study of Vinorelbine and Docetaxel in the Treatment of Advanced Non–Small-Cell Lung Cancer as Frontline and Second-Line Therapy
American Journal of Clinical Oncology: Cancer Clinical Trials - United States
doi 10.1097/coc.0b013e318199fb99
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2009
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)